Meribank Biotech Statistics

Total Valuation

TPEX:4724 has a market cap or net worth of TWD 1.49 billion. The enterprise value is 2.28 billion.

Market Cap	1.49B
Enterprise Value	2.28B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:4724 has 87.98 million shares outstanding. The number of shares has increased by 26.54% in one year.

Current Share Class	87.98M
Shares Outstanding	87.98M
Shares Change (YoY)	+26.54%
Shares Change (QoQ)	+24.08%
Owned by Insiders (%)	35.17%
Owned by Institutions (%)	0.81%
Float	44.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.07
PB Ratio	1.22
P/TBV Ratio	4.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-24.08
EV / Sales	6.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.95

Financial Position

The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.77.

Current Ratio	1.69
Quick Ratio	1.43
Debt / Equity	0.77
Debt / EBITDA	n/a
Debt / FCF	-3.29
Interest Coverage	-8.22

Financial Efficiency

Return on equity (ROE) is -10.27% and return on invested capital (ROIC) is -3.83%.

Return on Equity (ROE)	-10.27%
Return on Assets (ROA)	-2.93%
Return on Invested Capital (ROIC)	-3.83%
Return on Capital Employed (ROCE)	-3.59%
Revenue Per Employee	2.58M
Profits Per Employee	-666,979
Employee Count	142
Asset Turnover	0.20
Inventory Turnover	19.01

Taxes

Income Tax	-4.61M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.08% in the last 52 weeks. The beta is 0.03, so TPEX:4724's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	-56.08%
50-Day Moving Average	15.96
200-Day Moving Average	24.57
Relative Strength Index (RSI)	51.85
Average Volume (20 Days)	190,379

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4724 had revenue of TWD 366.43 million and -94.71 million in losses. Loss per share was -1.19.

Revenue	366.43M
Gross Profit	193.94M
Operating Income	-87.90M
Pretax Income	-101.55M
Net Income	-94.71M
EBITDA	-50.76M
EBIT	-87.90M
Loss Per Share	-1.19

Full Income Statement

Balance Sheet

The company has 165.09 million in cash and 942.84 million in debt, giving a net cash position of -777.75 million or -8.84 per share.

Cash & Cash Equivalents	165.09M
Total Debt	942.84M
Net Cash	-777.75M
Net Cash Per Share	-8.84
Equity (Book Value)	1.22B
Book Value Per Share	13.71
Working Capital	161.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -38.09 million and capital expenditures -248.61 million, giving a free cash flow of -286.70 million.

Operating Cash Flow	-38.09M
Capital Expenditures	-248.61M
Free Cash Flow	-286.70M
FCF Per Share	-3.26

Full Cash Flow Statement

Margins

Gross margin is 52.93%, with operating and profit margins of -23.99% and -25.85%.

Gross Margin	52.93%
Operating Margin	-23.99%
Pretax Margin	-27.71%
Profit Margin	-25.85%
EBITDA Margin	-13.85%
EBIT Margin	-23.99%
FCF Margin	n/a

Dividends & Yields

TPEX:4724 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.54%
Shareholder Yield	n/a
Earnings Yield	-6.35%
FCF Yield	-19.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:4724 has an Altman Z-Score of 0.97 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.97
Piotroski F-Score	1